Humanigen warns of bankruptcy after failing to bounce back after Covid-19 EUA rejection 

Humanigen warned in an SEC filing on Tuesday morning that it likely won’t survive after its Covid-19 antibody was rejected by the FDA in fall 2021.

The Short Hills, New Jersey-based biotech said it is “exploring all restructuring options, which may include commencing a bankruptcy…
Click here to view original post